ResearcherSichuan UniversityNo recent work listed
Qianwen Yu
Matched on OpenAlex author ID A5032276597. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2020: 1 paper · 2021: 1 paper
Papers 2
- Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using size-adjustable nanoparticles. Co-author DOI 10.1016/j.actbio.2021.05.002↗
- Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therap… Co-author DOI 10.1016/j.jconrel.2020.02.011↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zhirong Zhang · 2 shared papers, 2020–2021 · strength 0.22
- Paper Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using si… DOI 10.1016/j.actbio.2021.05.002↗
- Paper Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated … DOI 10.1016/j.jconrel.2020.02.011↗
- Man Li · 2 shared papers, 2020–2021 · strength 0.22
- Paper Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using si… DOI 10.1016/j.actbio.2021.05.002↗
- Paper Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated … DOI 10.1016/j.jconrel.2020.02.011↗
- Qin He · 2 shared papers, 2020–2021 · strength 0.22
- Paper Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using si… DOI 10.1016/j.actbio.2021.05.002↗
- Paper Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated … DOI 10.1016/j.jconrel.2020.02.011↗
- Jiao He · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.